Praxis Precision Medicines (PRAX) Non-Current Assets (2019 - 2026)

Praxis Precision Medicines' Non-Current Assets history runs 8 years deep, the most recent figure standing at $662.4 million for Q1 2026.

• On a quarterly basis, Non-Current Assets rose 356.34% year-over-year to $662.4 million in Q1 2026; TTM through Mar 2026 was $1.3 billion, a 245.23% increase from a year earlier, with the FY2025 full-year figure at $327.0 million, up 315.3% from the prior year.
• Non-Current Assets advanced to $662.4 million in Q1 2026 per PRAX's latest filing, from $327.0 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $662.4 million in Q1 2026 and bottomed at $3.1 million in Q4 2023.
• The 5-year median for Non-Current Assets is $38.6 million (2024), against an average of $99.7 million.
• Across the five-year window, Non-Current Assets declined 28.45% in 2023 and jumped 2466.43% in 2024, its largest moves.
• Year by year, Non-Current Assets stood at $4.3 million in 2022, then slipped by 28.45% to $3.1 million in 2023, then soared by 2466.43% to $78.7 million in 2024, then jumped by 315.3% to $327.0 million in 2025, then jumped by 102.58% to $662.4 million in 2026.
• Per Business Quant, the three latest PRAX Non-Current Assets figures stand at $662.4 million (Q1 2026), $327.0 million (Q4 2025), and $122.5 million (Q3 2025).